Showing results (261-270 of 3,079) with videos related to

Sort By:
Pageof 308
Drug Safety|August 28, 2001
Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosisC R Sirtori
Drug Safety|August 28, 2001
Antiretroviral therapy in pregnancy: a focus on safetyG P Taylor, N Low-Beer
Drug Safety|August 28, 2001
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoringD Layton, G L Pearce, S A Shakir
Drug Safety|November 28, 2002
Monitoring and assessing the safety of disease-modifying antirheumatic drugs: a West Midlands experienceParesh Jobanputra, Fiona Maggs, Dawn Homer, et al.
Drug Safety|July 3, 2002
Renal failure associated with the use of celecoxib and rofecoxibSyed R Ahmad, Cindy Kortepeter, Allen Brinker, et al.
Drug Safety|May 8, 2002
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overviewFabrizio De Ponti, Elisabetta Poluzzi, Andrea Cavalli, et al.
Drug Safety|June 23, 2001
Skin reactions to inhaled corticosteroidsM Isaksson
Drug Safety|August 12, 2003
Benefits and risks of simvastatin in patients with familial hypercholesterolaemiaPedro Mata, Rodrigo Alonso, Juan Badimón
Drug Safety|August 12, 2003
A feasibility study for recording of dispensing errors and near misses' in four UK primary care pharmaciesSiew-Siang Chua, Ian C K Wong, Hilary Edmondson, et al.
Drug Safety|January 22, 2003
Fenofibrate-induced hyperhomocysteinaemia: clinical implications and managementJutta Dierkes, Sabine Westphal, Claus Luley
Pageof 308